News

  • All
  • Cardiovascular
  • Central Nervous System
  • Gastroenterology
  • Respiratory
  • Syncrosome News
Syncrosome at the next Microbiome & Probotics Forum in Amsterdam

The 4th Microbiome R&D and Business collaboration Forum will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Amsterdam (Netherlands) from 3 to 4th of April. This conference will offer a complete programme focusing on preclinical animal model and specific focuses : Probiotics and Digestive Health (Roles...

Join Syncrosome team next week at Neuroscience Biopartnering Forum in New-York

Syncrosome invites you to visit us at 2nd Annual Neuroscience Biopartnering & Investment Forum, March 27th to March 28th, In New-York, USA. The Forum will be focused on Neurodegenerative Diseases with a mix of specialist panels and company presentations. It will be the occasion for Syncrosome to...

Nordic Day Syncrosome

The last january, all the Syncrosome laboratory an commercial team participated on a 2-day team building event in the French Alpes. It was an enthusiastic "scientific and sportive" experience for everyone! After different meetings to exchange on topics like: Important scientific and commercial results obtained in 2016, ...

Echocardiographic preclinical studies of Congestive heart failure

Congestive heart failure (CHF) is a serious outcome of myocardial infarction (MI). Animal models have been used to study various aspects of CHF. Postinfarction animal models have been extensively studied because myocardial ischemia and infarction are frequent causes of CHF in humans. However, not all...

Mechanism behind memory impairment caused by LPS neuro-inflammation

Alzheimer's disease (AD) is a progressive neuro-psychiatric disorder which is characterized by the formation of senile plaques (SPs), extracellular deposits of amyloid beta-peptides (Aβ) following intracellular neurofibrillary tangles (NFTs) of the microtubule-associated protein tau. Both cause neuronal degeneration, extensive loss of neurons and synaptic loss...

Syncrosome in French Alpes for a Special Nordic Team Event

  January 2017 is a great month for all the Syncrosome Laboratory and Commercial team. On Sunday 29th of January, all the team will be leaving for the French Alpes on a 2-day Team building experience. Our goal is to summarize Syncrosome’s 2016 life and events to...

Syncrosome: poster Preclinical PAH Sugen – European Respiratory Society meeting

Pulmonary arterial hypertension (PAH) is a rare cardiopulmonary disorder characterized by progressive obliteration of small pulmonary arterioles that leads to increased pulmonary vascular resistance. Because of impaired blood flow inpulmonary arteries, right ventricular pressure (RVSP) rises, ultimately leading toright ventricular failure and premature death. This...

Alpha synuclein Parkinson disease and pure autonomic failure in patients

To characterize the expression in skin nerves of native (n-syn) and misfolded phosphorylated (p-syn) α-synucleins in pure autonomic failure (PAF) and idiopathic Parkinson disease (IPD). The specific aims were to (1) define the importance of n-syn and p-syn as disease biomarkers and (2) ascertain differences...